These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33205459)

  • 1. Letter to the Editor: Should Growth Pattern of Hepatocellular Carcinoma Be Constant and Homogenous?
    Wang H; Mao Y; Huang M
    Hepatology; 2021 Jun; 73(6):2617-2618. PubMed ID: 33205459
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Several issues to consider in the study of hepatocellular carcinoma progression mechanism.
    Yang F; Jiang ST; Lu X; Xu Y; Zheng YC
    Hepatology; 2023 Jul; 78(1):E1-E2. PubMed ID: 35815365
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to Editor: Locoregional Therapy Before Liver Transplantation for Hepatocellular Carcinoma.
    Jiang N; Li X; Xing YF; Qiao YD; Chen J
    Hepatology; 2019 Oct; 70(4):1490-1491. PubMed ID: 31090941
    [No Abstract]   [Full Text] [Related]  

  • 4. Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro.
    Wu QF; Liu C; Tai MH; Liu D; Lei L; Wang RT; Tian M; Lü Y
    Acta Pharmacol Sin; 2010 Mar; 31(3):361-6. PubMed ID: 20154714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
    Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH
    Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the Editor: Serum bioavailable 25-hydroxyvitamin D levels correlate with hepatocellular carcinoma survival.
    Zhai LL; Zhen SH; Tang ZG
    Hepatology; 2022 Feb; 75(2):490-491. PubMed ID: 34536312
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor: Comment on "HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk".
    Sun L; Guan A; Liu M; Mao Y
    Hepatology; 2021 Jun; 73(6):2613-2614. PubMed ID: 33169424
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of KAI1 gene on the growth and invasion of human hepatocellular carcinoma MHCC97-H cells].
    Si SH; Yang JM; Peng ZH; Luo YH; Zhou P
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):615-6. PubMed ID: 16092995
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the Editor: Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma.
    Lai SW
    Hepatology; 2019 Jul; 70(1):440. PubMed ID: 30289991
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the Editor: Inflammation influences the prognosis of hepatocellular carcinoma.
    Liu X; Du S
    Int J Clin Oncol; 2022 Nov; 27(11):1791-1792. PubMed ID: 35962254
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From >1,000 to <500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
    Akbulut S; Sahin TT; Yilmaz S
    Hepatology; 2020 Dec; 72(6):2242-2243. PubMed ID: 32583464
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to letter to the editor: Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma.
    Wu CH; Shao YY; Ting-Fang Shih T
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):781-782. PubMed ID: 32950329
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor: Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis: Contrast-Enhanced Ultrasound May Be a Choice.
    Li J; Wang J; Yu S; Yuan G; He S
    Hepatology; 2020 Jan; 71(1):392. PubMed ID: 31222762
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of antisense survivin-liposome complex on cell growth, apoptosis and cell cycle in hepatocellular carcinoma cells].
    Dai DJ; Wu D; Meng H; Lu CD
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):581-5. PubMed ID: 16438864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor: Hepatic Resection Compared to Chemoembolization in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Comment For Moving Forward.
    Mo DC; Jia RR; Zhong JH
    Hepatology; 2019 Jul; 70(1):446-447. PubMed ID: 30520102
    [No Abstract]   [Full Text] [Related]  

  • 16. The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells.
    Yuanlong H; Haifeng J; Xiaoyin Z; Jialin S; Jie L; Li Y; Huahong X; Jiugang S; Yanglin P; Kaichun W; Jie D; Daiming F
    Cancer Lett; 2008 Sep; 268(1):110-9. PubMed ID: 18462868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter to the Editor: Use of Direct Liver Stiffness Measurement in Evaluating the Severity of Liver Cirrhosis in Patients with Hepatocellular Carcinoma.
    Pesce A; Feo CV
    World J Surg; 2021 Jan; 45(1):342-343. PubMed ID: 33043384
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate.
    Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ
    Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Author response to Letter to the Editor: 'Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?'.
    Wang C; He W; Li B; Yuan Y
    Liver Int; 2020 Jun; 40(6):1499-1500. PubMed ID: 32020771
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
    Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
    Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.